Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

45.75

-1.03 (-2.20%)

At close: Mar 27, 2026, 4:00 PM EDT

46.64

+0.89 (1.95%)

After-hours: Mar 27, 2026, 6:41 PM EDT

KNSA Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,501	3,147	1,434	1,236	1,044	813
Market Cap Growth	117.51%	119.41%	16.06%	18.37%	28.45%	-32.56%
Enterprise Value	3,097	2,740	1,199	1,040	856.08	633.31
Last Close Price	45.75	41.25	19.78	17.54	14.98	11.77
PE Ratio	61.00	55.00	-32.97	87.70	5.76	-5.12
Forward PE	38.13	27.32	42.93	-	-	-
PS Ratio	5.17	4.64	3.39	4.57	4.74	21.09
PB Ratio	6.15	5.54	3.27	2.82	2.64	4.39
P/TBV Ratio	6.37	5.74	3.22	2.88	2.66	4.36
P/FCF Ratio	25.67	23.07	56.44	93.83	183.11	-6.41
P/OCF Ratio	25.38	22.81	55.84	92.92	179.79	-6.44
EV/Sales Ratio	4.57	4.04	2.83	3.85	3.89	16.43
EV/EBITDA Ratio	39.31	34.78	-27.29	-45.48	70.31	-4.10
EV/EBIT Ratio	40.10	35.48	-26.28	-41.26	87.60	-4.04
EV/FCF Ratio	22.70	20.08	47.17	78.92	150.14	-5.00
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.01	0.01
Debt / EBITDA Ratio	0.12	0.12	-0.22	-0.54	0.49	-0.04
Debt / FCF Ratio	0.07	0.07	0.39	0.93	1.04	-0.05
Net Debt / Equity Ratio	-0.71	-0.71	-0.53	-0.44	-0.47	-0.95
Net Debt / EBITDA Ratio	-5.14	-5.14	5.32	8.49	-15.17	1.14
Net Debt / FCF Ratio	-2.97	-2.97	-9.20	-14.74	-32.39	1.39
Asset Turnover	1.01	1.01	0.76	0.55	0.64	0.13
Inventory Turnover	1.91	1.91	2.12	1.27	1.81	4.95
Quick Ratio	3.09	3.09	2.84	3.58	4.48	4.15
Current Ratio	3.79	3.79	3.30	4.34	5.16	4.38
Return on Equity (ROE)	11.73%	11.73%	-9.85%	3.37%	63.10%	-63.55%
Return on Assets (ROA)	18.04%	15.35%	-6.64%	-14.54%	-41.30%	-53.33%
Return on Invested Capital (ROIC)	49.50%	42.12%	-14.09%	-28.79%	-118.29%	-4448.43%
Return on Capital Employed (ROCE)	13.98%	13.98%	-9.68%	-5.76%	3.25%	-61.96%
Earnings Yield	1.69%	1.82%	-3.03%	1.14%	17.36%	-19.54%
FCF Yield	3.90%	4.33%	1.77%	1.07%	0.55%	-15.59%
Buyback Yield / Dilution	-10.58%	-10.58%	0.69%	-2.13%	-2.69%	-10.89%
Total Shareholder Return	-10.58%	-10.58%	0.69%	-2.13%	-2.69%	-10.89%

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q